ELOXX PHARMACEUTICALS, INC. Common Stock, Value, Issued
ELOXX PHARMACEUTICALS, INC. (ELOX) had Common Stock, Value, Issued of $40.00 thousand as of 2026-06-30, per its S-1 filed 2026-09-11.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:CommonStockValue · last filed 2026-09-11
- 2026-06-30: Common Stock, Value, Issued $40.00K.
- 2026-03-31: Common Stock, Value, Issued $5.00K; Common Stock, Value, Issued as first filed $51.00K.
- 2025-12-31: Common Stock, Value, Issued $4.00K; Common Stock, Value, Issued as first filed $48.00K.
- 2024-12-31: Common Stock, Value, Issued $3.00K; Common Stock, Value, Issued as first filed $35.00K.
| Period end | Common Stock, Value, Issued | Common Stock, Value, Issued as first filed |
|---|---|---|
| 2026-06-30 | $40.00K S-1 · filed 2026-09-11 | |
| 2026-03-31 | $5.00K S-1/A · filed 2026-06-04 | $51.00K 10-Q · filed 2026-05-05 |
| 2025-12-31 | $4.00K S-1 · filed 2026-09-11 | $48.00K 10-K · filed 2026-03-17 |
| 2024-12-31 | $3.00K S-1 · filed 2026-09-11 | $35.00K 10-K · filed 2026-03-17 |
| 2023-12-31 | $3.00K S-1 · filed 2026-09-11 | $31.00K 10-K · filed 2026-03-17 |
| 2023-09-30 | $31.00K 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $25.00K 10-Q · filed 2023-08-11 | |
| 2023-03-31 | $22.00K 10-Q · filed 2023-05-12 | |
| 2022-12-31 | $22.00K 10-Q · filed 2023-11-13 | |
| 2022-09-30 | $871.00K 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $871.00K 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $871.00K 10-Q · filed 2022-05-06 | |
| 2021-12-31 | $22.00K 10-K · filed 2023-03-31 | $871.00K 10-K · filed 2022-03-30 |
| 2021-09-30 | $863.00K 10-Q · filed 2021-11-08 | |
| 2021-06-30 | $863.00K 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $404.00K 10-Q · filed 2021-05-07 | |
| 2020-12-31 | $404.00K 10-K · filed 2022-03-30 | |
| 2020-09-30 | $403.00K 10-Q · filed 2020-11-06 | |
| 2020-06-30 | $403.00K 10-Q · filed 2020-08-07 | |
| 2020-03-31 | $403.00K 10-Q · filed 2020-05-08 | |
| 2019-12-31 | $402.00K 10-K · filed 2021-03-12 | |
| 2019-09-30 | $404.00K 10-Q · filed 2019-11-06 | |
| 2019-06-30 | $402.00K 10-Q · filed 2019-08-07 | |
| 2019-03-31 | $361.00K 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $360.00K 10-K · filed 2020-03-06 | |
| 2018-09-30 | $351.00K 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $349.00K 10-Q · filed 2018-08-10 | |
| 2018-03-31 | $274.00K 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $274.00K 10-K · filed 2019-03-14 | |
| 2017-09-30 | $514.15K 10-Q · filed 2017-11-14 | |
| 2017-06-30 | $292.03K 10-Q · filed 2017-11-14 | |
| 2017-03-31 | $269.21K 10-Q · filed 2017-05-22 | |
| 2016-12-31 | $42.00K 10-K · filed 2018-03-16 | $207.37K 10-Q · filed 2017-02-10 |
| 2016-09-30 | $204.96K 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $204.96K 10-K · filed 2017-10-13 | |
| 2016-03-31 | $204.21K 10-Q · filed 2016-05-12 | |
| 2015-12-31 | $204.21K 10-Q · filed 2016-02-16 | |
| 2015-09-30 | $203.88K 10-Q · filed 2015-11-16 | |
| 2015-06-30 | $187.53K 10-K · filed 2016-10-13 | |
| 2015-03-31 | $139.75K 10-Q · filed 2015-05-14 | |
| 2014-12-31 | $138.67K 10-Q · filed 2015-02-17 | |
| 2014-09-30 | $138.46K 10-Q · filed 2014-11-14 | |
| 2014-06-30 | $138.46K 10-K · filed 2015-10-09 | |
| 2014-03-31 | $68.98K 10-Q · filed 2014-05-09 | |
| 2013-12-31 | $49.57K 10-Q · filed 2014-02-14 | |
| 2013-09-30 | $23.48K 10-Q · filed 2013-11-14 | |
| 2013-06-30 | $22.72K 10-K · filed 2014-09-29 | $2.27M 10-K · filed 2013-09-11 |
| 2013-03-31 | $1.47M 10-Q · filed 2013-05-15 | |
| 2012-12-31 | $1.17M 10-Q · filed 2013-02-14 | |
| 2012-09-30 | $1.17M 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $941.13K 10-K · filed 2013-09-11 | |
| 2012-03-31 | $918.72K 10-Q · filed 2012-05-14 | |
| 2011-12-31 | $808.64K 10-Q · filed 2012-02-14 | |
| 2011-09-30 | $796.96K 10-Q · filed 2011-11-14 | |
| 2011-06-30 | $777.70K 10-K/A · filed 2012-10-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Tevogen Inc. (TVGN) | United States | $0.049B |